MYBL2 anticorps (N-Term)
Aperçu rapide pour MYBL2 anticorps (N-Term) (ABIN2310688)
Antigène
Voir toutes MYBL2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Réactivité croisée
- Humain, Souris, Rat (Rattus)
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu Mo Rt
-
Attributs du produit
- MYBL2 (Myb-like protein 2)
-
Purification
- Purified by immunoaffinity chromatography.
-
Immunogène
- A synthetic peptide corresponding to a sequence at the N-terminal of human MYBL2, identical to the related mouse sequence and different from the related rat sequence by two amino acids.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Reconstitution: Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
-
Buffer
- Supplied as a lyophilized powder. Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg Sodium azide.
-
Agent conservateur
- Sodium azide, Thimerosal (Merthiolate)
-
Précaution d'utilisation
- This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- 4°C/-20°C
-
-
- MYBL2 (V-Myb Myeloblastosis Viral Oncogene Homolog (Avian)-Like 2 (MYBL2))
-
Autre désignation
- MYBL2
-
UniProt
- P10244
-
Pathways
- Cycle Cellulaire, Mitotic G1-G1/S Phases, Chromatin Binding
Antigène
-